Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT01530087
Other study ID # 4518-O
Secondary ID CIV-GB-11-07-001
Status Terminated
Phase N/A
First received February 7, 2012
Last updated September 4, 2012
Start date January 2012
Est. completion date August 2012

Study information

Verified date September 2012
Source Hollister Incorporated
Contact n/a
Is FDA regulated No
Health authority United Kingdom: Medicines and Healthcare Products Regulatory Agency
Study type Observational

Clinical Trial Summary

The purpose of this study is to provide preliminary assessment of the safety and performance of a novel barrier formulation (CASTLE) in a small population of subjects with irritated peristomal skin.


Recruitment information / eligibility

Status Terminated
Enrollment 3
Est. completion date August 2012
Est. primary completion date February 2012
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- at least 18 years of age

- has colostomy or ileostomy

- current uses two piece tape bordered barrier

- has mild to moderate peristomal skin irritation

- cares for their stoma independently in the community

- at least 3 months post-operative

- provides informed consent

Exclusion Criteria:

- has fistula on or near stoma

- has been involved in stoma care study in the last 30 days

- is pregnant or lactating (determined by interview only)

- has existing medical condition that would compromise their participation or follow-up

- currently uses convex ostomy products, paste and/or rings

- is allergic to test barrier components

- is undergoing chemo- or radiotherapy that may affect the interpretation of the results

Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Device:
CASTLE barrier
Prototype barrier to be used in place of current two piece device

Locations

Country Name City State
United Kingdom York Teaching Hospital York

Sponsors (1)

Lead Sponsor Collaborator
Hollister Incorporated

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Peristomal skin irritation 30 days Yes
Secondary Security wear time leakage barrier erosion 30 days No